SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Translational Development Acquisition Corp.

(Name of Issuer)

Class A ordinary shares, $0.0001 par value

(Title of Class of Securities)

G9008W105

(CUSIP Number)

03/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No.

G9008W105

Names of Reporting Persons

Healthcare of Ontario Pension Plan Trust Fund

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 400,000.00
6	Shared Voting Power
7	Sole Dispositive Power 400,000.00
8	Shared Dispositive Power

Aggregate Amount Beneficially Owned by Each Reporting Person

400,000.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

2.3 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person: In reference to Rows 5, 7 and 9 above, amount consists of Class A ordinary shares, $0.0001 par value ("Class A Shares"), of Translational Development Acquisition Corp., a blank check company formed under the laws of the Cayman Islands (the "Issuer"). In reference to Row 11 above, percentage ownership is based on 17,250,000 Class A Shares issued and outstanding as of March 31, 2025, as reported on the Issuer's annual report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission on March 31, 2025.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Translational Development Acquisition Corp.

(b)

Address of issuer's principal executive offices:

52 E. 83rd Street, New York, New York 10028

Item 2.

(a)

Name of person filing:

Healthcare of Ontario Pension Plan Trust Fund ("HOOPP")

(b)

Address or principal business office or, if none, residence:

1 York Street, Suite 1900, Toronto, Ontario, Canada, M5J 0B6

(c)

Citizenship:

Ontario, Canada

(d)

Title of class of securities:

Class A ordinary shares, $0.0001 par value

(e)

CUSIP No.:

G9008W105

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

A pension plan formed as a trust under the laws of Ontario, Canada and registered with the Financial Services Regulatory Authority of Ontario.

Item 4.

Ownership

(a)

Amount beneficially owned:

See Item 9 on page 2.

(b)

Percent of class:

See Item 11 on page 2.

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

See Item 5 on page 2.

(ii) Shared power to vote or to direct the vote:

See Item 6 on page 2.

(iii) Sole power to dispose or to direct the disposition of:

See Item 7 on page 2.

(iv) Shared power to dispose or to direct the disposition of:

See Item 8 on page 2.

Item 5.

Ownership of 5 Percent or Less of a Class.

Ownership of 5 percent or less of a class

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the regulatory scheme applicable to a pension plan formed as a trust under the laws of Ontario, Canada and registered with the Financial Services Regulatory Authority of Ontario is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Securities and Exchange Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Healthcare of Ontario Pension Plan Trust Fund

Signature:	/s/ Abas Kanu
Name/Title:	VP, HOOPP Compliance Officer
Date:	05/14/2025

Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.